Kinnevik Investment


Upgrading our NAV; Babylon goes the SPAC route

03/06/21 -"We updated our estimated DCF following the announcement of Babylon Health's definitive merger agreement with the SPAC Alkuri Global, through which the London-based digital healthcare company will ..."

Pages
46
Language
English
Published on
03/06/21
You may also be interested by these reports :
11/06/21
Our target price and change of opinion reflect our recovered optimism in Worldline’s outlook. With the vaccine looking efficient and the consistent ...

11/06/21
In a letter addressed to Vivendi, Bolloré has committed to not ask the French market authority (AMF) for an exemption of launching a takeover bid on ...

08/06/21
Last time we teased about Bolloré (Add, France) over a year and half ago, we were not convinced by the family-run holding company, seeing competitive ...

07/06/21
We have updated our FY21-22 EPS estimates and rolled forward our forecasts until 2023. The changes to our estimates are mainly explained by higher ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO